Incensole

Incensole

SCHEMBL20565148

C/C1=C/CC2(C(C)C)CC[C@@](C)(O2)[C@H](O)CC/C(C)=C\CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 1.00
MET P08581 1/20 0.37
MEN1 O00255 1/20 0.35
CNR2 P34972 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARA Q07869 1/20 0.35
PTAFR P25105 2/20 0.34
HIF1A Q16665 4/20 0.33
EPAS1 Q99814 1/20 0.33
MAPK1 P28482 2/20 0.32
NLRP3 Q96P20 2/20 0.31
ALDH1A1 P00352 2/20 0.31
NFKB1 P19838 2/20 0.31
PKM P14618 1/20 0.31
CASP1 P29466 1/20 0.31
PTGS2 P35354 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Incensole SCHEMBL20565149 1.00 STAT3 (1.00) STAT3METMEN1CNR2KMT2A
Incensole SCHEMBL31471800 1.00 STAT3 (1.00) STAT3METMEN1CNR2KMT2A
Incensole SCHEMBL13394034 1.00 STAT3 (1.00) STAT3METMEN1CNR2KMT2A
Incensole SCHEMBL29369781 1.00 STAT3 (1.00) STAT3METMEN1CNR2KMT2A
SCHEMBL13394030 0.86 STAT3 (0.76) STAT3METMEN1CNR2KMT2A
SCHEMBL11451935 0.85 STAT3 (0.74) STAT3METMEN1CNR2KMT2A
SCHEMBL11451938 0.85 STAT3 (0.74) STAT3METMEN1CNR2KMT2A
SCHEMBL11451932 0.85 STAT3 (0.74) STAT3METMEN1CNR2KMT2A
SCHEMBL17405153 0.82 STAT3 (0.69) STAT3MEN1KMT2APTAFRHIF1A
SCHEMBL29516872 0.82 STAT3 (0.69) STAT3MEN1KMT2APTAFRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018213824-A2 THERAPEUTICS AND METHODS TO TREAT ANGIOGENESIS RELATED PATHOLOGIES Board of Supervisors for the University of Louisiana System (US) 2018-11-22 WO disclosed